Tvardi Therapeutics, Inc. ( TVRD) - Key Metrics
TVRD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.69 | -$0.99 | -$0.99 |
| 2026Q1 | $0 | -$0.73 | -$0.62 | -$0.62 |
| 2025Q4 | $0 | -$0.78 | -$0.61 | -$0.61 |
| 2025Q3 | $0 | -$0.59 | -$0.45 | -$0.45 |
| 2025Q2 | $0 | $0.51 | -$1.07 | -$1.07 |
TVRD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.69 |
| 2026Q1 | 0% | -1.09 |
| 2025Q4 | 0% | -1.38 |
| 2025Q3 | 0% | -16.51 |
| 2025Q2 | 0% | 11.44 |
TVRD
Price: $1.86
52 week price:
Earnings Per Share: -2.87 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 25.3 million